Alzheimer's Research & Therapy


Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Randall J Bateman*, Paul S Aisen, Bart De Strooper, Nick C Fox, Cynthia A Lemere, John M Ringman, Stephen Salloway, Reisa A Sperling, Manfred Windisch and Chengjie Xiong

Alzheimer's Research & Therapy 2011, 3:1 doi:10.1186/alzrt59

Accesses  

  • Last 30 days: 111 accesses
  • Last 365 days: 1327 accesses
  • All time: 3086 accesses

Cited by

BioMed Central: 3 citations

Editorial   Free

Recent Alzheimer's disease research highlights

Douglas Galasko, Todd Golde, Gordon Wilcock Alzheimer's Research & Therapy 2012, 4:14 (18 May 2012)

In their editorial, Editors-in-Chief Douglas Galasko, Todd Golde and Gordon Wilcock highlight several of the major translational research advances in Alzheimer's disease (AD) that have occurred over the past year.

Review   Subscription

Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease

Sascha Weggen, Dirk Beher Alzheimer's Research & Therapy 2012, 4:9 (30 March 2012)

The molecular consequences of amyloid precursor protein and presenilin gene mutations in familial Alzheimer's disease (FAD) are examined by Weggen and Beher; in view of potential therapeutic treatments directed at amyloid-beta peptides.

Commentary   Subscription

Defining and describing the pre-dementia stages of familial Alzheimer's disease

Natalie S Ryan, Martin N Rossor Alzheimer's Research & Therapy 2011, 3:29 (27 September 2011)

The need to establish a common framework for defining pre-dementia clinical stages of familial Alzheimer's disease (AD) is discussed by Ryan and Rosser, based on results from a recent study.